These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 28265777

  • 1. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
    Holloway RW, Ahmad S, Kendrick JE, Bigsby GE, Brudie LA, Ghurani GB, Stavitzski NM, Gise JL, Ingersoll SB, Pepe JW.
    Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ, Cohen D, Salani R, Cohn DE, O'Malley DM, Fanning E, Suarez AA, Fowler JM.
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.
    Sinno AK, Fader AN, Roche KL, Giuntoli RL, Tanner EJ.
    Gynecol Oncol; 2014 Aug; 134(2):281-6. PubMed ID: 24882555
    [Abstract] [Full Text] [Related]

  • 6. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging.
    Holloway RW, Bravo RA, Rakowski JA, James JA, Jeppson CN, Ingersoll SB, Ahmad S.
    Gynecol Oncol; 2012 Jul; 126(1):25-9. PubMed ID: 22507531
    [Abstract] [Full Text] [Related]

  • 7. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B, Valla M, Aune G, Ravlo M, Abusland AB, Araya E, Sundset M, Tingulstad S.
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [Abstract] [Full Text] [Related]

  • 8. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, Method M, Ade M, Ivanova A, Boggess JF.
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [Abstract] [Full Text] [Related]

  • 9. Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management: a prospective study.
    López-De la Manzanara Cano C, Cordero García JM, Martín-Francisco C, Pascual-Ramírez J, Parra CP, Céspedes Casas C.
    Int J Gynecol Cancer; 2014 Jul; 24(6):1048-53. PubMed ID: 24927249
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye.
    Buda A, Crivellaro C, Elisei F, Di Martino G, Guerra L, De Ponti E, Cuzzocrea M, Giuliani D, Sina F, Magni S, Landoni C, Milani R.
    Ann Surg Oncol; 2016 Jul; 23(7):2183-91. PubMed ID: 26714944
    [Abstract] [Full Text] [Related]

  • 12. Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green.
    Martinelli F, Ditto A, Bogani G, Signorelli M, Chiappa V, Lorusso D, Haeusler E, Raspagliesi F.
    J Minim Invasive Gynecol; 2017 Jan 01; 24(1):89-93. PubMed ID: 27725278
    [Abstract] [Full Text] [Related]

  • 13. The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma.
    Naaman Y, Pinkas L, Roitman S, Ikher S, Oustinov N, Vaisbuch E, Yachnin A, Ben-Arie A.
    Ann Surg Oncol; 2016 Feb 01; 23(2):450-5. PubMed ID: 26438438
    [Abstract] [Full Text] [Related]

  • 14. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
    Baiocchi G, Mantoan H, Kumagai LY, Gonçalves BT, Badiglian-Filho L, de Oliveira Menezes AN, Faloppa CC, De Brot L, da Costa AABA.
    Ann Surg Oncol; 2017 Dec 01; 24(13):3981-3987. PubMed ID: 29058141
    [Abstract] [Full Text] [Related]

  • 15. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
    Kim JH, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.
    World J Surg Oncol; 2018 Mar 09; 16(1):52. PubMed ID: 29523141
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
    Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT, Lu KH.
    Gynecol Oncol; 2017 Aug 09; 146(2):234-239. PubMed ID: 28528918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye.
    Papadia A, Zapardiel I, Bussi B, Ghezzi F, Ceccaroni M, De Ponti E, Elisei F, Imboden S, de la Noval BD, Gasparri ML, Di Martino G, De Santiago J, Mueller M, Vecchione F, Dell'Orto F, Buda A.
    J Cancer Res Clin Oncol; 2017 Mar 09; 143(3):475-480. PubMed ID: 27812854
    [Abstract] [Full Text] [Related]

  • 20. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
    Nagar H, Wietek N, Goodall RJ, Hughes W, Schmidt-Hansen M, Morrison J.
    Cochrane Database Syst Rev; 2021 Jun 09; 6(6):CD013021. PubMed ID: 34106467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.